STANDIGM

Standigm harnesses the power of AI to pioneer drug discovery, developing both proprietary and collaborative research pipelines. Our AI platform approach includes a biology platform for uncovering novel drug targets and a chemistry platform for designing molecules to modulate these targets effectively. In addition to pipeline development, we also offer AI platform services, empowering partners across the globe to accelerate their drug discovery processes and achieve groundbreaking advancements in medicine... We employ third party companies and individuals to facilitate our Website ("Service Providers"), to provide our Website on our behalf, to perform Website-related services or to assist us in analyzing how our Website is used. These third-parties have access to your personal information only to perform these tasks on our behalf and are obligated not to disclose or use it for any other purpose.

Also known as: Standigm Inc.

Primary location: Seoul South Korea